Key facts
- Kera’s last known valuation is $114.0M (Jun 2025).
- It has raised $13.0M; the latest was Seed Round ($10.0M) in Jun 2025.
- Notable investors include International Finance (Washington D.C.), TO VC (New York), The Raba Partnership, Wuri Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Kera
- ·The full record, as it builds
Funding rounds
No funding rounds for Kera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kera
Operator of a health tech platform intended to digitize and connect distributed information. The company's platform utilizes artificial intelligence to aggregate siloed data like lab results, pharmacies, intelligent health records, and health insurance products, enabling healthcare professionals to improve delivery and accessibility.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2022
- Employees
- 33
- Website
- kera.health/
- Ownership
- Privately Held (backing)
Kera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kera in its N-PORT filings yet. We sweep new filings monthly.